• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT PROLACTIN REAGENT KIT; RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT PROLACTIN REAGENT KIT; RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN) Back to Search Results
Catalog Number 07K76-25
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/03/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Section a1 - patient identifier: complete sid is (b)(6).This issue was previously reported under mdr number 3016438761-2024-00636 under a different suspect device.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The customer reported falsely elevated architect prolactin results generated on the architect i2000sr processing module for a patient.The physician questioned the result.The sample was sent out for a retest and the result was normal.The following data was provided: customer¿s reference range: 4 to 26 ng/ml.(b)(6)2024 sid (b)(6) architect prolactin result = 33.69 ng/ml.Retest result from another lab = 24.5 ng/ml.There was no impact to patient management reported.
 
Event or Problem Description
The customer reported falsely elevated architect prolactin results generated on the architect i2000sr processing module for a patient.The physician questioned the result.The sample was sent out for a retest and the result was normal.The following data was provided: customer¿s reference range: 4 to 26 ng/ml (b)(6) 2024 sid (b)(6) architect prolactin result = 33.69 ng/ml retest result from another lab = 24.5 ng/ml there was no impact to patient management reported.
 
Additional Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, a search for similar complaints, a ticket trending review, a device history record review, and a labeling review.In-house testing of retained reagent kit was also completed.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue.A ticket search by lot indicates that the reagent lot performs as expected for this product.The trending review did not identify any trends for the issue for the product.The device history record review did not identify any non-conformances or deviations with lot number 63009ud00 and the complaint issue.Labeling was reviewed and sufficiently addresses the customer's issue.Accuracy testing was completed using panels which mimic patient samples utilizing an in-house retained reagent kit stored at the recommended storage condition.All specifications were met indicating that the lot is performing acceptably.Based on this investigation, no systemic issue or deficiency with the architect prolactin reagent, lot number 63009ud00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT PROLACTIN REAGENT KIT
Common Device Name
RADIOIMMUNOASSAY, PROLACTIN (LACTOGEN)
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI  N39E932
Manufacturer (Section G)
ABBOTT IRELAND DIAGNOSTICS DIVISION
lisnamuck
co. longford
longford N39E9 32
EI   N39E932
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key20736352
Report Number3005094123-2024-00605
Device Sequence Number8362682
Product Code CFT
UDI-Device Identifier00380740014865
UDI-Public(01)00380740014865(17)250328(10)63009UD00
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/28/2025
Device Catalogue Number07K76-25
Device Lot Number63009UD00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/07/2024
Supplement Date Received by Manufacturer01/13/2025
Initial Report FDA Received Date11/20/2024
Supplement Report FDA Received Date01/14/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/27/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC I2000SR INST, 03M74-02, (B)(6).; ARC I2000SR INST, 03M74-02, (B)(6).
Patient SexUnknown
-
-